Displaying drugs 76 - 100 of 1617 in total
CDD-0102
Investigational
Matched Synonyms: … Cdd-0102 free base …
Matched Name: … CDD-0102 …
Matched Salts name: … CDD-0102 hydrochloride …
Matched Name: … CDD-0102 …
Matched Salts name: … CDD-0102 hydrochloride …
MK-0354
MK-0354, is an orally administered drug candidate under development by Merck for the treatment of atherosclerosis and related disorders. It targets G protein-coupled receptor, or GPCR, that have the potential to regulate plasma lipid profiles, including HDL, or the good cholesterol, similar to the therapeutic action of niacin.
Investigational
Matched Name: … MK-0354 …
Matched Description: … MK-0354, is an orally administered drug candidate under development by Merck for the treatment of atherosclerosis …
Matched Description: … MK-0354, is an orally administered drug candidate under development by Merck for the treatment of atherosclerosis …
FCX-013
FCX-013 consists of human dermal fibroblasts genetically modified with a lentiviral vector expressing metalloproteinase-1 (MMP-1).
Investigational
Matched Name: … FCX-013 …
Matched Description: … FCX-013 consists of human dermal fibroblasts genetically modified with a lentiviral vector expressing …
Matched Description: … FCX-013 consists of human dermal fibroblasts genetically modified with a lentiviral vector expressing …
AV-0113
AV-0113 consists of IL-12 secreting dendritic cells loaded with autologous tumor lysate.
Investigational
Matched Name: … AV-0113 …
Matched Description: … AV-0113 consists of IL-12 secreting dendritic cells loaded with autologous tumor lysate. …
Matched Description: … AV-0113 consists of IL-12 secreting dendritic cells loaded with autologous tumor lysate. …
PF-03758309
PF-03758309 has been used in trials studying the treatment of Advanced Solid Tumors.
Investigational
Matched Name: … PF-03758309 …
Matched Description: … PF-03758309 has been used in trials studying the treatment of Advanced Solid Tumors. …
Matched Salts name: … Pf 03758309 Hydrochloride …
Matched Description: … PF-03758309 has been used in trials studying the treatment of Advanced Solid Tumors. …
Matched Salts name: … Pf 03758309 Hydrochloride …
MBT-0312
MediGene's newly acquired drug candidates MBT-0312 aim at a novel method of cancer therapy by "starving out" tumors.
Investigational
Matched Name: … MBT-0312 …
Matched Description: … MediGene's newly acquired drug candidates MBT-0312 aim at a novel method of cancer therapy by "starving …
Matched Description: … MediGene's newly acquired drug candidates MBT-0312 aim at a novel method of cancer therapy by "starving …
AZD-0424
AZD0424 has been used in trials studying the treatment of Advanced Solid Tumours.
Investigational
Matched Name: … AZD-0424 …
VM4-037
VM4-037 is under investigation in clinical trial NCT00884520 (An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037).
Investigational
Matched Name: … VM4-037 …
Matched Description: … , Non-Randomized Study of [F-18]VM4-037). ... VM4-037 is under investigation in clinical trial NCT00884520 (An Exploratory, Open Label, Multi-Center …
Matched Description: … , Non-Randomized Study of [F-18]VM4-037). ... VM4-037 is under investigation in clinical trial NCT00884520 (An Exploratory, Open Label, Multi-Center …
ABBV-011
ABBV-011 is an antibody-drug conjugate of humanized, cysteine-engineered IgG1 monoclonal antibody targeting seizure-related 6 homolog conjugated to N-acetyl-gamma-calicheamicin.
Investigational
Matched Name: … ABBV-011 …
Matched Description: … ABBV-011 is an antibody-drug conjugate of humanized, cysteine-engineered IgG1 monoclonal antibody targeting …
Matched Description: … ABBV-011 is an antibody-drug conjugate of humanized, cysteine-engineered IgG1 monoclonal antibody targeting …
CTCE-0214
CTCE-0214 is a stable peptide agonist of stromal cell-derived factor-1 (SDF-1), a key signaling molecule in the proliferation, homing, engraftment and expansion of hematopoietic stem cells and white blood cells.
Investigational
Matched Name: … CTCE-0214 …
Matched Description: … CTCE-0214 is a stable peptide agonist of stromal cell-derived factor-1 (SDF-1), a key signaling molecule …
Matched Description: … CTCE-0214 is a stable peptide agonist of stromal cell-derived factor-1 (SDF-1), a key signaling molecule …
PM-060184
PM060184 has been used in trials studying Solid Tumors.
Investigational
Matched Name: … PM-060184 …
PD-0299685
PD-0299685 is under investigation in clinical trial NCT00314964 (Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause).
Investigational
Matched Name: … PD-0299685 …
Matched Description: … PD-0299685 is under investigation in clinical trial NCT00314964 (Study Evaluating PD-0299685 for the …
Matched Description: … PD-0299685 is under investigation in clinical trial NCT00314964 (Study Evaluating PD-0299685 for the …
PF-03187207
PF-03187207 is a nitric oxide-donating prostaglandin F2-alpha analogs for the potential treatment of glaucoma. Based on the very promising preclinical results and on the well-known activities of nitric oxide, PF-03187207 is expected to have an increased capacity to reduce high IOP. The development of abnormally high IOP, due to blockage...
Investigational
Matched Name: … PF-03187207 …
Matched Description: … PF-03187207 is a nitric oxide-donating prostaglandin F2-alpha analogs for the potential treatment of ... Based on the very promising preclinical results and on the well-known activities of nitric oxide, PF-03187207 …
Matched Description: … PF-03187207 is a nitric oxide-donating prostaglandin F2-alpha analogs for the potential treatment of ... Based on the very promising preclinical results and on the well-known activities of nitric oxide, PF-03187207 …
PF-00489791
PF-00489791 has been used in trials studying the treatment of Hypertension, Raynaud's Disease, Diabetic Nephropathies, Hypertension, Pulmonary, and Peripheral Vascular Disease.
Investigational
Matched Name: … PF-00489791 …
Matched Description: … PF-00489791 has been used in trials studying the treatment of Hypertension, Raynaud's Disease, Diabetic …
Matched Description: … PF-00489791 has been used in trials studying the treatment of Hypertension, Raynaud's Disease, Diabetic …
PF-04418948
Pf 04418948 is under investigation in clinical trial NCT01002963 (A Study To Investigate The Safety And Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers).
Investigational
Matched Name: … PF-04418948 …
Matched Description: … Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers). ... Pf 04418948 is under investigation in clinical trial NCT01002963 (A Study To Investigate The Safety And …
Matched Description: … Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers). ... Pf 04418948 is under investigation in clinical trial NCT01002963 (A Study To Investigate The Safety And …
PF-03715455
PF-03715455 has been used in trials studying the treatment of Asthma, Pulmonary Disease, Chronic Obstructive, and Chronic Obstructive Pulmonary Disease (COPD).
Investigational
Matched Name: … PF-03715455 …
Matched Description: … PF-03715455 has been used in trials studying the treatment of Asthma, Pulmonary Disease, Chronic Obstructive …
Matched Description: … PF-03715455 has been used in trials studying the treatment of Asthma, Pulmonary Disease, Chronic Obstructive …
PF-00446687
PF-00446687 has been investigated for the treatment of Erectile Dysfunction.
Investigational
Matched Name: … PF-00446687 …
Matched Description: … PF-00446687 has been investigated for the treatment of Erectile Dysfunction. …
Matched Description: … PF-00446687 has been investigated for the treatment of Erectile Dysfunction. …
PF-04995274
Pf 04995274 is under investigation in clinical trial NCT01193062 (Study In Healthy Subjects To Evaluate The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274).
Investigational
Matched Name: … PF-04995274 …
Matched Description: … Pf 04995274 is under investigation in clinical trial NCT01193062 (Study In Healthy Subjects To Evaluate ... The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274 …
Matched Description: … Pf 04995274 is under investigation in clinical trial NCT01193062 (Study In Healthy Subjects To Evaluate ... The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274 …
PF-04217903
PF-04217903 has been used in trials studying the treatment of Neoplasms.
Investigational
Matched Name: … PF-04217903 …
Matched Description: … PF-04217903 has been used in trials studying the treatment of Neoplasms. …
Matched Description: … PF-04217903 has been used in trials studying the treatment of Neoplasms. …
PF-03382792
Pf 03382792 is under investigation in clinical trial NCT01045863 (To Evaluate Safety, Tolerability, Plasma Drug Levels And Other Biological Effects In Healthy Volunteers).
Investigational
Matched Name: … PF-03382792 …
Matched Description: … Pf 03382792 is under investigation in clinical trial NCT01045863 (To Evaluate Safety, Tolerability, Plasma …
Matched Description: … Pf 03382792 is under investigation in clinical trial NCT01045863 (To Evaluate Safety, Tolerability, Plasma …
Displaying drugs 76 - 100 of 1617 in total